Draba nemorosa
Draba nemorosa · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Draba nemorosa is a specialized plant species that has garnered significant interest within the field of pharmacological research. Recent studies have focused specifically on the biological potential of its chemical constituents to combat malignancy. Investigations have demonstrated that 70% ethanol extracts of this plant exhibit notable antitumor activities. These preparations serve as a primary medium for isolating the bioactive compounds responsible for such therapeutic effects. Consequently, understanding the medicinal properties of Draba nemorosa remains a priority for developing new cancer treatment strategies.
- Synonyms
- Draba Nemorosa Var. Longipes · Tomostima Luteum · 26 more
- Common names
- Not available
- Family
- Brassicaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Draba nemorosa is a resilient plant known by a diverse array of common names across different linguistic traditions. In various regions, it is recognized by the names Draba dei boschi and Drave jaunatre. Those familiar with Lithuanian nomenclature might refer to it as Gojinė anksta. German speakers often identify the species as Hain-Felsenblümchen or Hain-Hungerblümchen. These varied titles reflect the wide geographical range and cultural presence of this unique wildflower.
Sources: Catalogue of Life (COL)
Synonyms
Draba nemorosa is a botanical subject characterized by a complex history of taxonomic classification. Throughout scientific literature, this species is frequently identified by several different synonyms, such as Crucifera nemorosa and Draba dictyota. Researchers also encounter it under the names Draba gracilis and Draba intermedia depending on the historical context of the study. Furthermore, the plant is sometimes referred to as Draba lutea var. longipes in specific botanical records. Understanding these various nomenclatural relationships is essential for maintaining accuracy in plant identification and research.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Draba nemorosa is a specialized organism belonging to the kingdom Plantae. Within this vast biological group, it is classified under the class Equisetopsida. The plant is further categorized into the order Brassicales, showcasing its evolutionary lineage. It specifically falls under the family Brassicaceae, which connects it to a wide range of mustard-like relatives. Finally, it is identified by its distinct genus, Draba.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Brassicales |
| Family | Brassicaceae |
| Genus | Draba |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Draba nemorosa is a resilient species primarily distributed throughout the Asia-Temperate regions. Its natural range extends through the mountainous landscapes of the Caucasus and the Transcaucasus. Furthermore, the plant is well-established across Central Asia, specifically within the borders of Kazakhstan. It can also be found flourishing in the diverse terrains of Kirgizstan and Tadzhikistan. These interconnected habitats highlight the wide geographical footprint this plant maintains across the Asian continent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Draba nemorosa is a self-supporting herb that grows in various environments. This plant maintains a compact growth form, typically reaching a maximum height of 0.5 meters. Depending on its specific conditions, its stature can be as minimal as 0.02 meters. This small scale makes it a subtle yet resilient addition to its native habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Draba nemorosa var. hebecarpa has demonstrated significant antitumor activity in recent comparative studies involving various Korean wild plants. During experimental testing against the P388D1 macrophage cell line, this specific plant extract effectively inhibited tumor cell viability by 37.31% at a concentration of 3 mg/mL. Its performance was particularly notable, as it yielded an inhibition concentration (IC50) value of 1.49 mg/mL. This finding places it among a select group of botanical extracts that show promise for medicinal applications. Consequently, the results suggest that Draba nemorosa may serve as a potential new agent in the development of antitumor therapies.
Compounds
Conditions
Draba nemorosa var. hebecarpa demonstrates significant antitumor activity by inhibiting the viability of tumor cells in vitro. In a comparative study involving 100 wild plants, this specific variety showed an inhibition rate of 37.31% at a concentration of 3 mg/mL. It also exhibited an inhibition concentration (IC50) value of 1.49 mg/mL during testing. These findings position the plant as a potential candidate for new antitumor agents. Consequently, its ability to treat tumor cells highlights its medicinal value within the studied group.
Preparations
Draba nemorosa var. hebecarpa is prepared as 70% ethanol extracts for use in antitumor studies. These specific extracts were tested for their ability to inhibit the viability of tumor cells within the P388D1 macrophage cell line. At a concentration of 3 mg/mL, the plant demonstrated an inhibition rate of 37.31%. The study further identified its inhibition concentration (IC50) value as 1.49 mg/mL. This preparation allows the plant to be evaluated alongside other wild plants and medicinal mushrooms as a potential antitumor agent.